Le Lézard
Classified in: Health, Covid-19 virus

FDAnews Announces Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19 Webinar Feb. 9, 2021


FALLS CHURCH, Va., Jan. 26, 2021 /PRNewswire-PRWeb/ -- Maintaining Your Risk-Based Cleaning and Disinfectant Programs:
Best Practices During COVID-19
An FDAnews Webinar
Tuesday, Feb. 9, 2021, 1:30 p.m.-3:00 p.m. EST
https://www.fdanews.com/riskbasedcleaning

The task of maintaining a controlled cleanroom is never simple and COVID-19 has made it more challenging. From COVID-19 monitoring to contact tracing and social distancing, cleanliness and sterilization remain essential during the pandemic.

This webinar will discuss the newest technologies to keep a cleanroom in a state of control. We'll also tackle the regulatory expectations around this requirement, including those of the FDA and international regulatory agencies.

Cleaning and disinfecting expert Jim Polarine will share tips on how to best design a risk-based program during this global health crisis. He will discuss industry trends, global regulatory expectations and how to maintain a controlled cleanroom. From his experienced perspective, attendees will learn what one needs to know to both meet written guidance and create the most sterile cleanroom feasible.

During this webinar, we will cover:

? Regulatory Expectations
         a. Requirements of FDA, Medicines and Healthcare Products Regulatory
             Agency (MHRA), Agência Nacional de Vigilância Sanitária (ANVISA),
             National Administration of Drugs, Foods and Medical Devices (ANMAT),
             Health Products Regulatory Authority (HPRA), European Medicines
             Agency (EMA) and Agence Nationale de Sécurité du Médicament et
             des Produits de Santé (ANSM) inspectors as they relate to COVID-19
         b. Lessons learned from FDA warning letters and 483s
? Guidance Documents
         a. Details in USP 43 (1072), PDA Technical Report #70 and other industry
             documents
         b. New guidance in Draft Annex I
? Basis Cleaning and Disinfection Frequencies
         a. Keeping cleanrooms controlled to ensure safe, pure and efficacious products
? Industry Best Practices
         a. Disinfecting during the COVID-19 pandemic
         b. Managing fungal and bacterial spore excursions
? The Latest Advances in Application Equipment and Cleaning Methods
         a. Disinfectant rotation, sterility, application and rinsing
         b. COVID-19 monitoring, contact tracing and social distancing
             requirements

Maintaining a cleanroom has become more difficult due COVID-19 but not impossible. With expert guidance, one can manage cleaning, disinfecting and sterilizing with best practices and a risk-based program.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.

Webinar Details:
Maintaining Your Risk-Based Cleaning and Disinfectant Programs:
Best Practices During COVID-19
An FDAnews Webinar
Tuesday, Feb. 9, 2021, 1:30 p.m.-3:00 p.m. EST
https://www.fdanews.com/riskbasedcleaning

Tuition:
$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/riskbasedcleaning
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

Media Contact

Michelle Butler, FDAnews, 703.538.7600, [email protected]

 

SOURCE FDAnews


These press releases may also interest you

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...



News published on and distributed by: